XML 48 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCK-BASED COMPENSATION
3 Months Ended
Mar. 31, 2014
STOCK-BASED COMPENSATION  
STOCK-BASED COMPENSATION

NOTE 11 — STOCK-BASED COMPENSATION

 

The Company issues stock options and restricted stock units to employees under Stock Awards Plans approved by shareholders.  Stock options are issued to non-employee directors for their services as directors under Director Stock Option Plans approved by shareholders.  Options are awarded with the exercise price equal to the market price on the date of grant and generally become exercisable over three years and expire 10 years after grant.  Restricted stock units generally vest over three years.

Compensation expense recorded attributable to stock options for the first three months of 2014 was approximately $8.4 million ($5.5 million after tax).  The income tax benefit related to this compensation expense was approximately $2.9 million.  Approximately $7.6 million of the compensation expense was recorded in selling, research & development and administrative expenses and the balance was recorded in cost of sales.  Compensation expense recorded attributable to stock options for the first three months of 2013 was approximately $6.5 million ($4.4 million after tax).  The income tax benefit related to this compensation expense was approximately $2.1 million.  Approximately $5.9 million of the compensation expense was recorded in selling, research & development and administrative expenses and the balance was recorded in cost of sales.

The Company uses historical data to estimate expected life and volatility.  The weighted-average fair value of stock options granted under the Stock Awards Plans was $14.84 and $10.07 per share in 2014 and 2013, respectively.  These values were estimated on the respective dates of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions:

 

 

Stock Awards Plans:

 

 

 

 

 

Three months ended March 31,

 

2014

 

2013

 

 

 

 

 

 

 

Dividend Yield

 

1.7

%

1.8

%

Expected Stock Price Volatility

 

22.2

%

22.7

%

Risk-free Interest Rate

 

2.3

%

1.2

%

Expected Life of Option (years)

 

6.9

 

6.9

 

 

There were no grants under the Director Stock Option Plan during the three months ended March 31, 2014 and 2013.

 

A summary of option activity under the Company’s stock plans as of March 31, 2014, and changes during the three months then ended is presented below:

 

 

 

 

Stock Awards Plans

 

Director Stock Option Plans

 

 

 

 

 

Weighted Average

 

 

 

Weighted Average

 

 

 

Shares

 

Exercise Price

 

Shares

 

Exercise Price

 

 

 

 

 

 

 

 

 

 

 

Outstanding, January 1, 2014

 

7,815,932

 

$

41.26

 

313,834

 

$

48.85

 

Granted

 

1,349,850

 

68.00

 

--

 

--

 

Exercised

 

(216,498

)

33.82

 

--

 

--

 

Forfeited or expired

 

(19,400

)

50.18

 

--

 

--

 

Outstanding at March 31, 2014

 

8,929,884

 

$

45.47

 

313,834

 

$

48.85

 

Exercisable at March 31, 2014

 

6,252,800

 

$

39.23

 

146,000

 

$

42.05

 

 

 

 

 

 

 

 

 

 

 

Weighted-Average Remaining Contractual Term (Years):

 

 

 

 

 

Outstanding at March 31, 2014

 

6.5

 

 

 

7.3

 

 

 

Exercisable at March 31, 2014

 

5.3

 

 

 

5.9

 

 

 

 

 

 

 

 

 

 

 

 

 

Aggregate Intrinsic Value ($000):

 

 

 

 

 

 

 

 

 

Outstanding at March 31, 2014

 

$

186,827

 

 

 

$

5,415

 

 

 

Exercisable at March 31, 2014

 

$

168,000

 

 

 

$

3,511

 

 

 

 

 

 

 

 

 

 

 

 

 

Intrinsic Value of Options Exercised ($000) During the Three Months Ended:

 

 

 

 

 

March 31, 2014

 

$

6,912

 

 

 

$

--

 

 

 

March 31, 2013

 

$

16,515

 

 

 

$

--

 

 

 

 

The fair value of shares vested during the three months ended March 31, 2014 and 2013 was $13.0 million and $12.1 million, respectively.  Cash received from option exercises was approximately $2.4 million and the actual tax benefit realized for the tax deduction from option exercises was approximately $7.8 million in the three months ended March 31, 2014.  As of March 31, 2014, the remaining valuation of stock option awards to be expensed in future periods was $21.0 million and the related weighted-average period over which it is expected to be recognized is 1.6 years.

The fair value of restricted stock unit grants is the market price of the underlying shares on the grant date.  A summary of restricted stock unit activity as of March 31, 2014, and changes during the period then ended is presented below:

 

 

 

 

 

 

Weighted-Average

 

 

 

Shares

 

Grant-Date Fair Value

 

 

 

 

 

 

 

Nonvested at January 1, 2014

 

25,681

 

$

53.49

 

Granted

 

43,671

 

67.57

 

Vested

 

(9,355

)

52.50

 

Nonvested at March 31, 2014

 

59,997

 

$

63.90

 

 

Compensation expense recorded attributable to restricted stock unit grants for the first three months of 2014 and 2013 was approximately $733 thousand and $416 thousand, respectively.  The fair value of units vested during the three months ended March 31, 2014 and 2013 was $491 thousand and $496 thousand, respectively.  The intrinsic value of units vested during the three months ended March 31, 2014 and 2013 was $613 thousand and $582 thousand, respectively.  As of March 31, 2014 there was $2.7 million of total unrecognized compensation cost relating to restricted stock unit awards which is expected to be recognized over a weighted-average period of 1.8 years.

During the first quarter of 2014, the Company approved a new long-term incentive program for certain employees.  The program is based on the cumulative total shareholder return of our common stock during a three year performance period.  Total expense related to this program is expected to be approximately $1.2 million over the performance period, of which $159 thousand was recognized in the first quarter of 2014.